Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Rogé M, Pointreau Y, Sargos P, Meyer E, Schick U, Hasbini A, Rio E, Bera G, Ruffier A, Quivrin M, Chasseray M, Latorzeff I, Martin E, Guimas V, Pommier P, Leroy T, Ronchin P, Lepinoy A, Grand A, Cartier L, Didas O, Denis F, Libois V, Blanc-Lapierre A, Supiot S. Rogé M, et al. Among authors: ruffier a. Clin Transl Radiat Oncol. 2023 Mar 8;40:100613. doi: 10.1016/j.ctro.2023.100613. eCollection 2023 May. Clin Transl Radiat Oncol. 2023. PMID: 36968576 Free PMC article.
Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
Pointreau Y, Bensadoun RJ, Bera G, Sire C, Ruffier A, Janoray G, Calais G, Bollet M, Pinel B, Braniste V, Amores X. Pointreau Y, et al. Among authors: ruffier a. Patient Prefer Adherence. 2020 May 21;14:859-868. doi: 10.2147/PPA.S246757. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32546980 Free PMC article.
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial.
Castelli J, Thariat J, Benezery K, Hasbini A, Gery B, Berger A, Liem X, Guihard S, Chapet S, Thureau S, Auberdiac P, Pommier P, Ruffier A, Perrier L, Devillers A, Campillo-Gimenez B, de Crevoisier R. Castelli J, et al. Among authors: ruffier a. JAMA Oncol. 2023 Aug 1;9(8):1056-1064. doi: 10.1001/jamaoncol.2023.1352. JAMA Oncol. 2023. PMID: 37261806 Free article.
[Clinical research in private sector: Which strategic analysis?].
Ruffier A, Pointreau Y, Sacier V, Balavoine M, Lamrani-Ghaouti A, Guihard S, Rivera S. Ruffier A, et al. Cancer Radiother. 2023 Sep;27(6-7):469-473. doi: 10.1016/j.canrad.2023.06.023. Epub 2023 Aug 16. Cancer Radiother. 2023. PMID: 37596122 French.
[French experience in paediatric total body irradiation: A study from the radiotherapy committee of the Société française des cancers de l'enfant (SFCE)].
Demoor-Goldschmidt C, Supiot S, Claude L, Carrie C, Mazeron R, Helfré S, Alapetite C, Jouin A, Coche B, Padovani L, Muracciole X, Bernier V, Vigneron C, Noël G, Leseur J, Le Prisé É, Stefan D, Habrand JL, Kerr C, Bondiau PY, Ruffier A, Chapet S, Mahé MA. Demoor-Goldschmidt C, et al. Among authors: ruffier a. Cancer Radiother. 2016 Jun;20(4):304-7. doi: 10.1016/j.canrad.2016.02.011. Epub 2016 Jun 21. Cancer Radiother. 2016. PMID: 27342946 French.
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Tao Y, Biau J, Sun XS, Sire C, Martin L, Alfonsi M, Prevost JB, Modesto A, Lafond C, Tourani JM, Miroir J, Kaminsky MC, Coutte A, Liem X, Chautard E, Vauleon E, Drouet F, Ruffier A, Ramee JF, Waksi G, Péchery A, Wanneveich M, Guigay J, Aupérin A, Bourhis J. Tao Y, et al. Among authors: ruffier a. Ann Oncol. 2023 Jan;34(1):101-110. doi: 10.1016/j.annonc.2022.10.006. Epub 2022 Oct 28. Ann Oncol. 2023. PMID: 36522816 Free article. Clinical Trial.
[French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)].
Demoor-Goldschmidt C, Claude L, Carrie C, Bolle S, Helfre S, Alapetite C, Jouin A, Padovani L, Ducassou A, Vigneron C, Le Prisé É, Huchet A, Stefan D, Kerr C, Nguyen TD, Truc G, Chapet S, Bondiau PY, Coche B, Muracciole X, Laprie A, Noël G, Leseur J, Habrand JL, Potet H, Ruffier A, Supiot S, Mahé MA, Bernier V. Demoor-Goldschmidt C, et al. Among authors: ruffier a. Cancer Radiother. 2016 Jul;20(5):395-9. doi: 10.1016/j.canrad.2016.05.016. Epub 2016 Jul 13. Cancer Radiother. 2016. PMID: 27421622 French.
17 results